Browse All

Current Filters

CLEAR FILTER x

TITLE

ENCORE: Topline Results of a Phase Three Open-label Extension and Randomized-withdrawal Trial of AXS-12 in Narcolepsy

Author:Bogan, Richard   Thorpy, Michael   Krahn, Lois   Corser, Bruce   Shapiro, Colin   Chen, Dan   Chhabra, Angad   Leary, Eileen   Tabuteau, Herriot   

Session Name:P6: Sleep: Disorders of Excessive Daytime Somnolence  

Topic:Sleep  

Program Number:P6.006  

Author Institution:Medical University of South Carolina, Charleston, SC  Montefiore Medical Center, Sleep-Wake Disorders Center, Bronx, NY  Mayo Clinic College of Medicine, Phoenix, AZ  Intrepid Research, Cincinatti, OH  University of Toronto, Toronto, ON, Canada  Axsome Therapeutics, Inc., New York, NY  Formerly of Axsome Therapeutics, Inc., San Francisco, CA  

Once-nightly Sodium Oxybate Improves Symptoms in People With Narcolepsy: Interim Results From the Real-world REFRESH Study

Author:Meskill, Sarah   Meskill, Gerard   Roy, Asim   Santamaria, Adrian   Porpiglio, Robyn   Mamedov, Oktai   Ibrahim, Sally   Bailey, Omavi   Bogan, Richard   Herpel, Laura B.   mcconnell, jeremy   Richards, Gretchen S.   Abaluck, Brian   Gudeman, Jennifer   

Session Name:P6: Sleep: Disorders of Excessive Daytime Somnolence  

Topic:Sleep  

Program Number:P6.007  

Author Institution:Tricoastal Narcolepsy and Sleep Disorder Center, Sugar Land, TX  Tricoastal Narcolepsy and Sleep Disorders Center, Sugar Land, TX  Ohio Sleep Medicine Institute, Dublin, OH  NW HOUSTON NEUROLOGY AND COMPREHENSIVE SLEEP, Tomball, TX  Ghaly Sleep Management Services, LLC, East Syracuse, NY  Comprehensive Sleep Center, East Lansing, MI  University Hospitals Cleveland Medical Center, Cleveland, OH  Biorhythms, El Paso, TX  University of South Carolina School of Medicine and Medical University of South Carolina, SC  Bogan Sleep Consultants, Columbia, SC  Florida Sleep Specialists, Bradenton, FL  Avadel Pharmaceuticals, Chesterfield, MO  

Samelisant (SUVN-G3031) for the Treatment of Cataplexy in Patients With Narcolepsy Type-one: Rationale and Study Design of a Phase-two Study

Author:Jayarajan, Pradeep   Goyal, Vinod Kumar   Shinde, Anil   Jetta, Satish   Palacharla, Veera Raghava Chowdary   Benade, Vijay   Abraham, Renny   Pandey, Santosh Kumar   Subramanian, Ramkumar   Mohammed, Abdul Rasheed   Nirogi, Ramakrishna   

Session Name:P6: Sleep: Disorders of Excessive Daytime Somnolence  

Topic:Sleep  

Program Number:P6.008  

Author Institution:Suven Life Sciences Ltd, Hyderabad, India  Suven Life Sciences, Hyderabad, India  

Residual Symptom Burden in Patients With Narcolepsy Satisfied With Treatment: Subgroup Analysis From the CRESCENDO Survey

Author:Thorpy, Michael   Kant, Amy   Harper, Keith   Leary, Eileen   Eglit, Graham   Floam, Samantha   Tabuteau, Herriot   

Session Name:P6: Sleep: Disorders of Excessive Daytime Somnolence  

Topic:Sleep  

Program Number:P6.009  

Author Institution:Montefiore Medical Center, Sleep-Wake Disorders Center, Bronx, NY  Narcolepsy Network, Camas, WA  Formerly of Axsome Therapeutics, Inc., San Francisco, CA  Axsome Therapeutics, Inc., New York, NY  

Demographics and Comorbidities of Patients With Narcolepsy: A Propensity Score–Matched Cohort Study

Author:Soltis, Marjorie   Lipford, Melissa   Smither, Allison   Gudeman, Jennifer   

Session Name:P6: Sleep: Disorders of Excessive Daytime Somnolence  

Topic:Sleep  

Program Number:P6.010  

Author Institution:Duke University Medical Center, Durham, NC  Mayo Clinic, Rochester, MN  nference, Cambridge, MA  Avadel Pharmaceuticals, Chesterfield, MO